Dr. Laura Gioia is a clinician-researcher and expert in Stroke Neurology at the Centre Hospitalier de l'Université de Montréal (CHUM) and Principal Scientist at the CRCHUM. Her clinical and research work focuses on the diagnosis and management of acute ischemic stroke and intracerebral hemorrhage, with the overarching goal of improving prehospital management of acute stroke.

Dr. Gioia has developed a research program evaluating the role of novel technologies including blood-based biomarkers, telemedicine, and measures of neurophysiology to improve prehospital acute stroke management. This work is pursued in collaboration with Emergency Medical Services providers, as well as national and international partners. She also serves as a member of the Board of the Canadian Stroke Consortium and Co-Chair of the CSC's Prehospital Working Group, where she works to build prehospital stroke research capacity across Canada.

Her research program is supported by a salary award from the Fonds de recherche du Québec-Santé (FRQS) as well as research grants from the Heart and Stroke Foundation of Canada, the Canadian Institutes of Health Research, Brain Canada and the CQDM, and philanthropic support from the Durocher Foundation,

Dr. Gioia has disclosed financial relationships with Bayer and AstraZeneca Canada, including receipt of speaker honoraria and participation in advisory boards. She also receives research funding and salary support through funded research studies supported by the Heart and Stroke Foundation, the Canadian Institutes of Health Research (CIHR), Brain Canada, the Fonds de recherche du Québec – Santé (FRQS), and AstraZeneca Canada.